- 著者
- Kana Moriyama Daisuke Sasaki Yuichi Ono
- 出版者
- Fuji Technology Press Ltd.
- 雑誌
- Journal of Disaster Research (ISSN:18812473)
- 巻号頁・発行日
- vol.13, no.6, pp.1007-1014, 2018-11-01 (Released:2018-11-01)
- 参考文献数
- 26
- 被引用文献数
- 22
After the Sendai Framework for Disaster Risk Reduction is adopted, a global database as a tool to monitor disaster loss and damage databases is required. Several disaster loss and damage databases are in use globally. This paper aims to explore how the existing databases vary in three aspects of threshold, spatial resolution, and data quality control, as well as the limitations of the existing databases. We review previous studies comparing the existing global databases and extract the differences and limitations. The threshold of EM-DAT is clear, but its threshold results in ignoring small-scale disasters that DesInventar captures. The differences in disaster threshold create different pictures of disaster losses and/or risks. Regarding spatial resolution, only DesInventar provides disaster impact data at a municipal level, while others provide information at a country level. The limitations of the existing global database are categorized into four aspects, as follows: lack of disaggregated data, limited spatial coverage and resolution, insufficiency of completeness and reliability of data, and insufficient information on indirect loss. The implication from our findings is that, in order to complement the limitations of the existing disaster loss databases to use for decision making on disaster risk reduction, the following are required: cross-checking of data across different databases; complementary disaster loss data; and collection of an exhaustive and firsthand dataset with a transparent and internationally consistent methodology by policy makers.
- 著者
- Yasuhiro Maejima Kiyoshi Nobori Yuichi Ono Susumu Adachi Jun-ichi Suzuki Kenzo Hirao Mitsuaki Isobe Hiroshi Ito for the Heart Failure by Coadministration of Statin and Angiotensin-II Receptor Blocker (HF-COSTAR) Trial Investigators
- 出版者
- 日本循環器学会
- 雑誌
- Circulation Journal (ISSN:13469843)
- 巻号頁・発行日
- vol.75, no.3, pp.589-595, 2011 (Released:2011-02-25)
- 参考文献数
- 38
- 被引用文献数
- 5 11
Background: It is known that HMG-CoA reductase inhibitors (statins) may have a therapeutic benefit in patients with heart failure (HF). However, no studies have yet evaluated the possible interaction of statins and angiotensin-II receptor blockers (ARBs) on left ventricular (LV) function in patients with HF. We hypothesized that statins might alter the effect of ARBs on cardiac function in patients with HF. Methods and Results: We prospectively randomized patients with chronic HF who received the ARB, losartan (LOS group), or the statin, simvastatin (SIM), in combination with LOS (SIM+LOS group) at our hospitals and assessed before and after treatment for 6 months. Although no significant improvement of HF symptoms as evaluated by the New York Heart Association (NYHA) classification was observed in the LOS group, HF symptoms in the SIM+LOS group significantly improved. The percent increase of LV ejection fraction after treatment in the SIM+LOS group was significantly larger than in the LOS group. Furthermore, the plasma brain natriuretic peptide level was significantly lower after treatment in the SIM+LOS group than in the LOS group. Conclusions: Combined statin and ARB therapy significantly improves both symptoms and LV function over time in patients with HF. Thus, the combination of an ARB with a statin may be a useful therapeutic strategy for HF. (Circ J 2011; 75: 589-595)